Aescin (a mixture of triterpene saponins) works through: (1) capillary permeability reduction — aescin inhibits the enzyme hyaluronidase, which degrades the "mortar" (glycosaminoglycans) between endothelial cells, strengthening capillary walls; (2) venous tone increase — aescin stimulates PGF2α release, causing venoconstriction (tightening of venous walls); (3) anti-inflammatory — inhibits phospholipase A2, reducing prostaglandin and leukotriene production; (4) lymphatic drainage improvement. The net effect: less fluid leaks out of capillaries (reducing edema) and veins are tighter (reducing blood pooling and varicose appearance).
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.